Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $118.3400 (2.66%) ($115.0400 - $118.9000) on Wed. Jun. 8, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.91% (three month average) | RSI | 46 | Latest Price | $118.3400(2.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.1% a day on average for past five trading days. | Weekly Trend | LGND declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) XBI(56%) IWO(55%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -0.955% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.955% (StdDev 1.91%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
Resistance Level | $118.83 | 5 Day Moving Average | $117.51(0.71%) | 10 Day Moving Average | $119.1(-0.64%) | 20 Day Moving Average | $118.83(-0.41%) | To recent high | -9.2% | To recent low | 21.9% | Market Cap | $1.902b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |